Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 4/20 | 0.41 |
| ▸ | HAVCR2 | Q8TDQ0 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | ALB | P02768 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.37 |
| ▸ | OXTR | P30559 | 1/20 | 0.37 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13066052 | 0.93 | SLC5A2 (0.45) | SLC5A2HAVCR2ESR1P2RY6CA9 | |
| SCHEMBL13024566 | 0.92 | P2RY6 (0.50) | SLC5A2HAVCR2ESR1P2RY6CA9 | |
| SCHEMBL10293948 | 0.92 | P2RY6 (0.46) | SLC5A2HAVCR2ESR1P2RY6CA9 | |
| SCHEMBL13066251 | 0.92 | HAVCR2 (0.38) | SLC5A2HAVCR2ESR1P2RY6CA9 | |
| SCHEMBL14597192 | 0.91 | ESR1 (0.40) | SLC5A2HAVCR2ESR1P2RY6CA9 | |
| SCHEMBL10293918 | 0.90 | P2RY6 (0.44) | SLC5A2HAVCR2ESR1P2RY6CA9 | |
| SCHEMBL13065979 | 0.89 | P2RY6 (0.42) | SLC5A2HAVCR2ESR1P2RY6CA9 | |
| SCHEMBL13065978 | 0.88 | P2RY6 (0.44) | SLC5A2HAVCR2ESR1P2RY6CA9 | |
| SCHEMBL13066101 | 0.86 | SLC5A2 (0.42) | SLC5A2HAVCR2ESR1P2RY6CA9 | |
| SCHEMBL14051238 | 0.86 | P2RY6 (0.45) | SLC5A2HAVCR2ESR1P2RY6CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100280246-A1 | ENERGY TRANSFER DYES WITH ENHANCED FLUORESCENCE | APPLERA CORPORATION (US) | 2010-11-04 | — | — | US | disclosed |
| US-7432058-B2 | Methods of labeling nucleic acids with energy transfer dyes | APPLERA CORPORATION (US) | 2008-10-07 | — | — | US | disclosed |
| US-20070154927-A1 | ENERGY TRANSFER DYES WITH ENHANCED FLUORESCENCE | APPLERA CORPORATION (US) | 2007-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100280246-A1 | ENERGY TRANSFER DYES WITH ENHANCED FLUORESCENCE | SLC25A21, ZCCHC8, ZDHHC7 | SLC5A2 2548/4885HAVCR2 4252/4885ESR1 2242/4885 |
| US-20070154927-A1 | ENERGY TRANSFER DYES WITH ENHANCED FLUORESCENCE | SLC25A21, ZCCHC8, SLC25A1 | SLC5A2 2454/4885HAVCR2 4168/4885ESR1 2046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.